Navigate Up
Launch the Developer Dashboard
The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS clinical trials networks of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.
Read more about our mission​ ​​​​​​


​Get Involved in HIV/AIDS Clinical Trials

Learn more about participating in a clinical research study or engaging your community in clinical trials research.

Calandar Image

HANC Calendar

​Check for scientific conferences, network meetings, community events, training dates, etc. 

Training Resources

​View a variety of training resources including the online HIV Research Counseling and Testing (HRCT) curriculum, HSP and GCP training.

Lab Resources

​Find info for labs such as procedures and SOPs.


ACTG/IMPAACT Lab Manual Link


​Legacy Project

Learn how HANC is working to increase participation of underrepresented populations in HIV clinical trials.

HANC is supported through a cooperative
agreement with the National Institute of Allergy
and Infectious Disease (NIAID)

Find us, follow us, friend us:

   Link to FHCRC

Announ​cem​ents ​

COVID-19 Resources

HANC will maintain and frequently update a new page: Resources and information on the COVID-19 pandemic with a focus on the intersection with the HIV pandemic. Find the page under the Resources tab or link directly here​.

Network Announcements on COVID-19
HIV/AIDS Clinical Trials Network announcements in response to COVID-19 are also available here​

Laboratory Guidance related to COVID-19 is available here​

COVID-19 & HIV Update: Impact on Communities and HIV/AIDS Clinical Research

Aired April 2, 2020.

As COVID-19 continues to have devastating impact on individuals, communities and societies​ globally, the need for accurate, concise, and timely updates is critical. In an effort to provide current and relevant information, the Office of HIV/AIDS Network Coordination (HANC) is hosting a webinar to inform network stakeholders and community about the impact of COVID-19 on HIV Research. The recording is available here​.

Characterizing Loneliness among YBMSM: Considerations toward Sexual Health and Well-being

April 8, 2020 @ 10AM PT / 1PM ET

The Legacy Project invites you to join a webinar highlighting the impact of social disconnection prompted by the results of a study of loneliness among a Chicago cohort of young Black men who have sexual relationships with men (YBMSM). Register here.

TB Vaccine Development Update / HVTN 602

April 20, 2020 @ 10AM PT / 1PM ET

Community Partners and the Tuberculosis Trials Consortium invite you to join Dr. Jim Kublin, Executive Director of the HVTN, to review the TB vaccine candidate pipeline and discuss results of HVTN 602/Aeras A-042, a phase 1b randomized study to assess how the immune system responds to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mtb-uninfected adolescents conducted in South Africa. Register here.

Virtually (Not) Impossible: Novel Approaches Utilizing Online Platforms to Address Disparities in HIV Prevention

April 22, 2020 @ 10AM PT / 1PM ET

This webinar will explore novel methods of data collection among sexual minority individuals using mobile technologies, and examine approaches to engage traditionally marginalized MSM via online platforms. Register here​.

NEW HIV Language Guide

In collaboration with the Legacy Project and many other reviewers, the National Institute of Allergy and Infectious Diseases has developed a language guide to encourage the use of affirming and non-stigmatizing language among NIAID staff. Access the document here​.  

Guidance for Transgender Inclusive Research

The Division of AIDS Cross-Network Transgender Working Group has released a document to focus attention on inclusive practices for study protocol development and design, data collection, and data reporting. Click here to access the document.

Community Resource - Long-Acting Antiretroviral Injectables Info Sheet

A Long-Acting Antiretroviral Injectables (LAARVI) Information Sheet was developed on behalf of Legacy to provide general information about LAARVI. The info sheet can be found on the Community Resources page or directly linked here.

Digg Delicious Facebook Newsvine Reddit StumbleUpon Twitter Email Link




© HIV/AIDS Network Coordination